Salt Lake City

Salt Lake City, Utah 84148

1 studies enrolling now · 12 studies all time

What they study most

C. Diff, C. Difficile, CDI, Clostridium Difficile Infection, Clostridium Difficile Infection Recurrence, Contraception, Endometriosis, Endometriosis Related Pain, FMT, Fecal Microbiota, Fecal Transplant, Heart Failure With Preserved Ejection Fraction

Studies at this site

• A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis — Recruiting now
• A Study of TX000045 in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (the APEX Study) — Running, not enrolling
• Study of the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women With Uterine Fibroids or Endometriosis Who Are at Risk for Pregnancy — Completed
• LIBERTY EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids — Completed
• SPIRIT EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Endometriosis-Associated Pain — Completed
• Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent C. Diff — Completed
• Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection — Completed
• LIBERTY 1: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids — Completed
• SPIRIT 2: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated Pain — Completed
• SPIRIT 1: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated Pain — Completed
• A Study of OMP-313M32 in Subjects With Locally Advanced or Metastatic Solid Tumors — Stopped early
• Minimizing Harm From ADEs by Improving Nurse-Physician Communication — Completed